Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

US FDA CDER, CBER Staff Say Pandemic Had Negative Effect On Hiring, Retention

Executive Summary

Human resource managers also worried that since universal teleworking was valued by employees, a return to pre-pandemic conditions could cause a mass exodus.

You may also be interested in...



US FDA Drug Center Medical Officer Hiring ‘Doing Well’

CDER Director Cavazzoni is seeing ‘net gains’ in hiring, including in key areas like medical officers. The agency still has lagging areas of need, like statisticians and inspector/investigators.

US FDA Opens OTP Director Search Again

The new job notice offers a top salary, but also invites questions about the candidate pool attracted by the original solicitation.

FDA’s Cell, Gene Therapy Office Head Wilson Bryan Set To Retire

OTAT Director Bryan, who has worked at the FDA for more than 20 years, will depart by the end of March as the agency’s cell and gene therapy operations are poised for a major overhaul and a large number of new hires.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS145859

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel